Search Results

You are looking at 1 - 8 of 8 items for :

  • Hormones and Cancer x
Clear All
Orwa Dandash Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Orwa Dandash in
Google Scholar
PubMed
Close
,
James Allebone Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by James Allebone in
Google Scholar
PubMed
Close
,
Adam Mirabelli Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Adam Mirabelli in
Google Scholar
PubMed
Close
,
Nicholas Russell Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Nicholas Russell in
Google Scholar
PubMed
Close
,
Mathis Grossmann Department of Endocrinology, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Close
,
Andrea Gogos Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia
Department of Florey Institute, University of Melbourne, Parkville, Victoria, Australia

Search for other papers by Andrea Gogos in
Google Scholar
PubMed
Close
, and
Richard A Kanaan Department of Psychiatry, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia

Search for other papers by Richard A Kanaan in
Google Scholar
PubMed
Close

mL (0.9 mg) per day for 6 months and (ii) matching placebo group that received placebo gel 1 mL per day. Randomization occurred by stratifying participants by ADT duration (≤3 or >3 months) and then by eligibility to undergo brain MRI scanning

Open access
Hanna Karhapää Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Hanna Karhapää in
Google Scholar
PubMed
Close
,
Siru Mäkelä Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Siru Mäkelä in
Google Scholar
PubMed
Close
,
Hanna Laurén Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for other papers by Hanna Laurén in
Google Scholar
PubMed
Close
,
Marjut Jaakkola Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Radiology, HUS Medical Imaging Centre, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

Search for other papers by Marjut Jaakkola in
Google Scholar
PubMed
Close
,
Camilla Schalin-Jäntti Medical Faculty, University of Helsinki, Helsinki, Finland
Endocrinology, Abdominal Centre, University of Helsinki and HUS, Helsinki, Finland

Search for other papers by Camilla Schalin-Jäntti in
Google Scholar
PubMed
Close
, and
Micaela Hernberg Medical Faculty, University of Helsinki, Helsinki, Finland
Department of Oncology, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland

Search for other papers by Micaela Hernberg in
Google Scholar
PubMed
Close

University Hospital with in-house methods. A whole-body CT and a brain MRI or a brain CT were performed prior to treatment initiation as well. Before each treatment cycle, we measured WBC, CRP, sodium, potassium, calcium, creatinine, ALT, ALP, bilirubin

Open access
Carole Morin Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Carole Morin in
Google Scholar
PubMed
Close
,
Keo-Morakort Benedetto Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Keo-Morakort Benedetto in
Google Scholar
PubMed
Close
,
Agathe Deville Hospices Civils de Lyon, Hôpital Louis Pradel, Médecine Nucléaire, Bron, France
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France

Search for other papers by Agathe Deville in
Google Scholar
PubMed
Close
,
Laurent Milot Hospices Civils de Lyon, Hôpital Edouard Herriot, Radiologie, Lyon Cedex 03, France
University of Lyon, Université Lyon 1, France

Search for other papers by Laurent Milot in
Google Scholar
PubMed
Close
,
Aurélie Theillaumas Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Aurélie Theillaumas in
Google Scholar
PubMed
Close
,
Valérie Hervieu Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Institut de Pathologie Est, Bron Cedex, France

Search for other papers by Valérie Hervieu in
Google Scholar
PubMed
Close
,
Mathieu Pioche University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Gastroentérologie, Lyon Cedex 03, France

Search for other papers by Mathieu Pioche in
Google Scholar
PubMed
Close
,
Gilles Poncet Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France

Search for other papers by Gilles Poncet in
Google Scholar
PubMed
Close
,
Julien Forestier Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Julien Forestier in
Google Scholar
PubMed
Close
,
Laurent François Hospices Civils de Lyon, Hôpital Louis Pradel, Exploration Fonctionnelle, Bron Cedex, France

Search for other papers by Laurent François in
Google Scholar
PubMed
Close
,
Francoise Borson-Chazot University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Louis Pradel, Endocrinologie, Bron Cedex, France

Search for other papers by Francoise Borson-Chazot in
Google Scholar
PubMed
Close
,
Mustapha Adham University of Lyon, Université Lyon 1, France
Hospices Civils de Lyon, Hôpital Edouard Herriot, Chirurgie Digestive, Lyon Cedex 03, France

Search for other papers by Mustapha Adham in
Google Scholar
PubMed
Close
,
Catherine Lombard-Bohas Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France

Search for other papers by Catherine Lombard-Bohas in
Google Scholar
PubMed
Close
, and
Thomas Walter Hospices Civils de Lyon, Hôpital Edouard Herriot, Oncologie Digestive, Lyon Cedex 03, France
Centre de Recherche en Cancérologie de Lyon, UMR Inserm 1052 CNRS 5286, Lyon Cedex 08, France
University of Lyon, Université Lyon 1, France

Search for other papers by Thomas Walter in
Google Scholar
PubMed
Close

-up and the initial treatments was defined according to ENETS guidelines (French guidelines are similar) ( 3 , 6 ). Minimal work-up included laboratory test (chromogranin A), endoscopy along with endoscopic ultrasound (EUS), imaging (CT scan, MRI, and

Open access
Jiaxin Luo Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Jiaxin Luo in
Google Scholar
PubMed
Close
,
Weili Yin Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Weili Yin in
Google Scholar
PubMed
Close
,
Qiuxia Lin The Second School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Qiuxia Lin in
Google Scholar
PubMed
Close
,
Juqing Wu Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Juqing Wu in
Google Scholar
PubMed
Close
,
Pan Chen Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Pan Chen in
Google Scholar
PubMed
Close
,
Yuanna Ling Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Yuanna Ling in
Google Scholar
PubMed
Close
,
Jing Wang Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Jing Wang in
Google Scholar
PubMed
Close
,
Zhen Li Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Zhen Li in
Google Scholar
PubMed
Close
,
Liqin Pan Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Liqin Pan in
Google Scholar
PubMed
Close
,
Yanying Chen Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Yanying Chen in
Google Scholar
PubMed
Close
,
Wei Ouyang Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Wei Ouyang in
Google Scholar
PubMed
Close
, and
Huijuan Feng Department of Nuclear Medicine, Zhujiang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

Search for other papers by Huijuan Feng in
Google Scholar
PubMed
Close

RAIT and the collecting conditions of the post-therapy whole-body scans ( 16 ). Additional SPECT/CT images were performed immediately for suspected bone metastases with I-131 uptake, and CT or MRI examinations were performed within 1 month after RAIT to

Open access
Matteo Scopel Medical Clinic III, Department of Medicine (DIMED), University Hospital of Padua, Padua, Italy

Search for other papers by Matteo Scopel in
Google Scholar
PubMed
Close
,
Eugenio De Carlo Medical Clinic III, Department of Medicine (DIMED), University Hospital of Padua, Padua, Italy

Search for other papers by Eugenio De Carlo in
Google Scholar
PubMed
Close
,
Francesca Bergamo Unit of Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Search for other papers by Francesca Bergamo in
Google Scholar
PubMed
Close
,
Sabina Murgioni Unit of Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Search for other papers by Sabina Murgioni in
Google Scholar
PubMed
Close
,
Riccardo Carandina Radiodiagnostic Unit, University Hospital of Padua, Padua, Italy

Search for other papers by Riccardo Carandina in
Google Scholar
PubMed
Close
,
Anna Rita Cervino Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy

Search for other papers by Anna Rita Cervino in
Google Scholar
PubMed
Close
,
Marta Burei Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy

Search for other papers by Marta Burei in
Google Scholar
PubMed
Close
,
Federica Vianello Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto IOV-IRCCS, Padua, Italy

Search for other papers by Federica Vianello in
Google Scholar
PubMed
Close
,
Vittorina Zagonel Unit of Medical Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy

Search for other papers by Vittorina Zagonel in
Google Scholar
PubMed
Close
,
Matteo Fassan Surgical Pathology Unit, Department of Medicine (DIMED), University of Padua, Padua, Italy

Search for other papers by Matteo Fassan in
Google Scholar
PubMed
Close
, and
Roberto Vettor Medical Clinic III, Department of Medicine (DIMED), University Hospital of Padua, Padua, Italy

Search for other papers by Roberto Vettor in
Google Scholar
PubMed
Close

medicine reports were mainly taken into consideration. All patients underwent total-body PET/CT imaging with 68 Ga-SSA, MRI and fluorodeoxyglucose-PET/CT focused on bone lesions. Patients who presented reports of ambiguous interpretation were discarded due

Open access
Mark J C van Treijen Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Mark J C van Treijen in
Google Scholar
PubMed
Close
,
Catharina M Korse Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Catharina M Korse in
Google Scholar
PubMed
Close
,
Wieke H Verbeek Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Gastroenterology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Wieke H Verbeek in
Google Scholar
PubMed
Close
,
Margot E T Tesselaar Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands
Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

Search for other papers by Margot E T Tesselaar in
Google Scholar
PubMed
Close
, and
Gerlof D Valk Department of Endocrine Oncology, University Medical Center Utrecht, Utrecht, The Netherlands
Center for Neuroendocrine Tumors, ENETS Center of Excellence, Netherlands Cancer Institute, University Medical Center Utrecht, Utrecht, The Netherlands

Search for other papers by Gerlof D Valk in
Google Scholar
PubMed
Close

with a median of 4 samples per patient (range: 2–12) in an average of 46 months of follow-up (6–71 months). CT was the most common imaging modality used ( n  = 533), followed by DOTA-PET/CT ( n  = 118) and MRI ( n  = 71). During follow-up, 70 patients

Open access
Ruth Percik Institute of Endocrinology, Diabetes and Metabolism, Sheba Medical Centre, Ramat Gan, Israel

Search for other papers by Ruth Percik in
Google Scholar
PubMed
Close
,
Sherwin Criseno Department of Endocrinology, University Hospital Birmingham, Birmingham, UK

Search for other papers by Sherwin Criseno in
Google Scholar
PubMed
Close
,
Safwaan Adam Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK

Search for other papers by Safwaan Adam in
Google Scholar
PubMed
Close
,
Kate Young Royal Marsden Hospital, London, UK

Search for other papers by Kate Young in
Google Scholar
PubMed
Close
, and
Daniel L Morganstein Department of Endocrinology, Chelsea and Westminster Hospital, London, UK
Royal Marsden Hospital, London, UK

Search for other papers by Daniel L Morganstein in
Google Scholar
PubMed
Close

-stimulating hormone (TSH) and gonadotrophin deficiency ( 12 , 18 , 19 ). We, therefore, propose that hypophysitis should be reserved to describe either the symptomatic phase with headache or MRI findings of enlarged pituitary, whilst ICPI-induced hypopituitarism is

Open access
Hélène Singeisen Department of Internal Medicine, Endocrinology, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Hélène Singeisen in
Google Scholar
PubMed
Close
,
Mariko Melanie Renzulli Institute of Radiology, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Mariko Melanie Renzulli in
Google Scholar
PubMed
Close
,
Vojtech Pavlicek Department of Internal Medicine, Endocrinology, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Vojtech Pavlicek in
Google Scholar
PubMed
Close
,
Pascal Probst Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Pascal Probst in
Google Scholar
PubMed
Close
,
Fabian Hauswirth Department of Surgery, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Fabian Hauswirth in
Google Scholar
PubMed
Close
,
Markus K Muller Department of Surgery, Cantonal Hospital Thurgau, Frauenfeld, Switzerland

Search for other papers by Markus K Muller in
Google Scholar
PubMed
Close
,
Magdalene Adamczyk Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Search for other papers by Magdalene Adamczyk in
Google Scholar
PubMed
Close
,
Achim Weber Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland

Search for other papers by Achim Weber in
Google Scholar
PubMed
Close
,
Reto Martin Kaderli Department of Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland

Search for other papers by Reto Martin Kaderli in
Google Scholar
PubMed
Close
, and
Pietro Renzulli Department of Surgery, Cantonal Hospital Thurgau, Münsterlingen, Switzerland

Search for other papers by Pietro Renzulli in
Google Scholar
PubMed
Close

endocrine tumors in MEN4 and MEN1, respectively. For MEN1, this percentage amounts to 20% for clinically apparent adenomas and up to 40% if adenomas detected by hormonal testing or MRI screening are included ( 3 , 7 , 8 , 14 , 47 ). With regards to MEN4

Open access